267 related articles for article (PubMed ID: 28052822)
1. Applying a Conceptual Framework to Maximize the Participation of Diverse Populations in Cancer Clinical Trials.
Napoles A; Cook E; Ginossar T; Knight KD; Ford ME
Adv Cancer Res; 2017; 133():77-94. PubMed ID: 28052822
[TBL] [Abstract][Full Text] [Related]
2. Involving South Asian patients in clinical trials.
Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
[TBL] [Abstract][Full Text] [Related]
3. Training Needs of Clinical and Research Professionals to Optimize Minority Recruitment and Retention in Cancer Clinical Trials.
Niranjan SJ; Durant RW; Wenzel JA; Cook ED; Fouad MN; Vickers SM; Konety BR; Rutland SB; Simoni ZR; Martin MY
J Cancer Educ; 2019 Feb; 34(1):26-34. PubMed ID: 28776305
[TBL] [Abstract][Full Text] [Related]
4. Closing the divide: diverse populations and cancer survivorship.
Guidry JJ; Torrence W; Herbelin S
Cancer; 2005 Dec; 104(11 Suppl):2577-83. PubMed ID: 16258930
[TBL] [Abstract][Full Text] [Related]
5. Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT).
Durant RW; Wenzel JA; Scarinci IC; Paterniti DA; Fouad MN; Hurd TC; Martin MY
Cancer; 2014 Apr; 120 Suppl 7(0 7):1097-105. PubMed ID: 24643647
[TBL] [Abstract][Full Text] [Related]
6. Strategies To Boost Minority Participation in Clinical Trials.
Fillon M
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 30053208
[No Abstract] [Full Text] [Related]
7. Enrolling Minority and Underserved Populations in Cancer Clinical Research.
Wallington SF; Dash C; Sheppard VB; Goode TD; Oppong BA; Dodson EE; Hamilton RN; Adams-Campbell LL
Am J Prev Med; 2016 Jan; 50(1):111-117. PubMed ID: 26470805
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Vaccine Decision-making Factors in Racial and Ethnic Minority Communities in Los Angeles, California.
Carson SL; Casillas A; Castellon-Lopez Y; Mansfield LN; Morris D; Barron J; Ntekume E; Landovitz R; Vassar SD; Norris KC; Dubinett SM; Garrison NA; Brown AF
JAMA Netw Open; 2021 Sep; 4(9):e2127582. PubMed ID: 34591103
[TBL] [Abstract][Full Text] [Related]
9. Patient barriers to cancer clinical trial participation and navigator activities to assist.
Cartmell KB; Bonilha HS; Simpson KN; Ford ME; Bryant DC; Alberg AJ
Adv Cancer Res; 2020; 146():139-166. PubMed ID: 32241387
[TBL] [Abstract][Full Text] [Related]
10. Perceived Institutional Barriers Among Clinical and Research Professionals: Minority Participation in Oncology Clinical Trials.
Niranjan SJ; Wenzel JA; Martin MY; Fouad MN; Vickers SM; Konety BR; Durant RW
JCO Oncol Pract; 2021 May; 17(5):e666-e675. PubMed ID: 33974821
[TBL] [Abstract][Full Text] [Related]
11. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Engagement of Racial and Ethnic Minorities in HIV Treatment and Vaccine Clinical Trials: A Scoping Review of Literature and Implications for Future Research.
Bass SB; D'Avanzo P; Alhajji M; Ventriglia N; Trainor A; Maurer L; Eisenberg R; Martinez O
AIDS Patient Care STDS; 2020 Sep; 34(9):399-416. PubMed ID: 32931317
[TBL] [Abstract][Full Text] [Related]
13. Increasing minority patient participation in cancer clinical trials using oncology nurse navigation.
Holmes DR; Major J; Lyonga DE; Alleyne RS; Clayton SM
Am J Surg; 2012 Apr; 203(4):415-22. PubMed ID: 21996347
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers.
Barrett NJ; Rodriguez EM; Iachan R; Hyslop T; Ingraham KL; Le GM; Martin K; Haring RC; Rivadeneira NA; Erwin DO; Fish LJ; Middleton D; Hiatt RA; Patierno SR; Sarkar U; Gage-Bouchard EA
Cancer; 2020 Mar; 126(5):1077-1089. PubMed ID: 31909824
[TBL] [Abstract][Full Text] [Related]
15. Participation in cancer trials: recruitment of underserved populations.
Paskett ED; Katz ML; DeGraffinreid CR; Tatum CM
Clin Adv Hematol Oncol; 2003 Oct; 1(10):607-13. PubMed ID: 16258457
[TBL] [Abstract][Full Text] [Related]
16. Responses to a theoretically adapted clinical trial education session: faith-based sites versus rural work site dissemination.
Aumiller BB; Parrott R; Lengerich EJ; Dominic O; Camacho F; Lehman E; Gallant NR; Loughran TP
J Cancer Educ; 2013 Dec; 28(4):698-708. PubMed ID: 23884547
[TBL] [Abstract][Full Text] [Related]
17. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
18. Statewide Tuskegee Alliance for clinical trials. A community coalition to enhance minority participation in medical research.
Fouad MN; Partridge E; Wynn T; Green BL; Kohler C; Nagy S
Cancer; 2001 Jan; 91(1 Suppl):237-41. PubMed ID: 11148586
[TBL] [Abstract][Full Text] [Related]
19. Facilitating the recruitment of minority ethnic people into research: qualitative case study of South Asians and asthma.
Sheikh A; Halani L; Bhopal R; Netuveli G; Partridge MR; Car J; Griffiths C; Levy M
PLoS Med; 2009 Oct; 6(10):e1000148. PubMed ID: 19823568
[TBL] [Abstract][Full Text] [Related]
20. Diverse populations and enrollment in pediatric cancer clinical trials: Challenges and opportunities.
Aristizabal P
Pediatr Blood Cancer; 2020 Nov; 67(11):e28296. PubMed ID: 32343877
[No Abstract] [Full Text] [Related]
[Next] [New Search]
